Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
Asset Publisher
Neulasta®; Fulphila™; Udenyca™; Ziextenzo™, Nyvepria™; Fylnetra®, Stimufend; Rolvedon®; Ryzneuta®; Pegfilgrastim-fpgk§